IL2 and neuroblastoma: The resulting construct hu14.18–IL-21 ICK stimulated CD8+ T cells and M1 tumor-associated macrophages, decreased the recruitment of immunosuppressive cells to the TME, and mediated potent antitumor cytotoxicity against neuroblastoma more efficiently than hu14.18–IL-2 [136].